TLR9 and arthritic joint disease: Studies have shown that inhibition of TLR9 prior to disease onset significantly reduces arthritis and almost completely eliminates bone erosion, and reduces serum IL-6, a-1-acid glycoprotein, and rheumatoid factor levels in PIA rats.